Benefit brokers have a growing opportunity to help clients incorporate comparative effectiveness research into value-based health plan design, a just-released survey suggests. They will, however, have to gain ground on other resources employers are turning to in their search for the most trusted adviser.
Employers have, for some time, expressed desires to reward use of the most effective treatments for containing costs and restoring workers’ health. But a survey commissioned by the National Pharmaceutical Council offers new insight on employers’ desire to bring CER to bear on plan design.
